Selectivity in Psychotropic Drug Action - Promises or Problems?
First Statement of Responsibility
edited by Svein G. Dahl, Lars F. Gram, Steven M. Paul, William Z. Potter.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Berlin, Heidelberg
Name of Publisher, Distributor, etc.
Springer Berlin Heidelberg
Date of Publication, Distribution, etc.
1986
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(xii, 290 pages 79 illustrations)
SERIES
Series Title
Psychopharmacology series, 3.
CONTENTS NOTE
Text of Note
Molecular Pharmacology in Drug Development --;Molecular Modeling in Drug Design --;Synthesis of New Peptides Based on Models of Receptor-Bound Conformation --;Molecular Approach to the Mechanism of Action of Antidepressant Drugs --;Anxiolytics --;Modulation of the Benzodiazepine-GABA Receptor Chloride Ionophore Complex by Multiple Allosteric Sites: Evidence for a Barbiturate 'Receptor' --?-Carbolines: New Insights into the Clinical Pharmacology of Benzodiazepine Receptor Ligands --;Pharmacodynamic Approaches to Benzodiazepine Action in Man --;Correlating Pharmacokinetics and Pharmacodynamics of Benzodiazepines: Problems and Assumptions --;Benzodiazepine-Serotonin Interactions in Man --;Comparative Pharmacodynamics of Benzodiazepines --;Abuse Liability of Triazolam: Experimental Measurements in Animals and Humans --;Clinical Studies of 'Specific' Anxiolytics as Therapeutic Agents --;Antidepressants --;Regulation of Beta Adrenergic and Serotonin-S2 Receptors in Brain by Electroconvulsive Shock and Serotonin --?2-Adrenoceptor Antagonists as Antidepressants: The Search for Selectivity --;GABA Synapses, Depression, and Antidepressant Drugs --;Antidepressant Monoamine Oxidase Inhibitors Enhance Serotonin but not Norepinephrine Neurotransmission --;Selective Amine Oxidase Inhibitors: Basic to Clinical Studies and Back --;Therapeutic Effect of Selective 5HT Reuptake Inhibitors in Comparison with Tricyclic Antidepressants --;Accidental Antidepressants: Search for Specific Action --;Antidepressants and EEG Sleep: Search for Specificity --;Possible Teratogenic Effects of Imipramine in the Rat --;Pharmacological Specificity Is Not the Same as Clinical Selectivity --;Pharmacokinetic Considerations Relevant to the Pharmacodynamics of Antidepressants --;Receptor Assay Based on 3H-Imipramine Binding --;Neuroleptics --;Pharmacological Validation of the Two-Dopamine-Receptor Hypothesis --;Differential Regulation of Dopamine-D2 and Serotonin-S2 Receptors by Chronic Treatment with the Serotonin-S2 Antagonists, Ritanserin and Setoperone --;Chronic Neuroleptic Effects on Dopamine Neuron Activity: A Model for Predicting Therapeutic Efficacy and Side Effects? --;Effect of Selective D1 and D2 Dopamine Receptor Antagonists and Agonists in Cebus Monkeys: Implications for Acute and Tardive Dyskinesias. A Preliminary Report --;Neuroleptic-lnduced Parkinsonism Increases with Repeated Treatment in Monkeys --;Biochemical Alterations Produced by Neuroleptics in Man: Studies of Plasma Homo vanillic Acid in Schizophrenic Patients --;Effect of Neuroleptics on the Schizophrenic Syndrome --;Pharmacokinetic and Pharmacodynamic Factors Causing Variability in Response to Neuroleptic Drugs --;List of Participants.
SUMMARY OR ABSTRACT
Text of Note
The Fourth International Meeting on Clinical Pharmacology in Psychiatry was held in Bethesda, Maryland on 5-8 September 1985 and was dedicated to the memory of Dr. Earl Usdin.
TOPICAL NAME USED AS SUBJECT
Medicine.
Psychiatry.
Toxicology.
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RM315
Book number
.
E358
1986
PERSONAL NAME - PRIMARY RESPONSIBILITY
edited by Svein G. Dahl, Lars F. Gram, Steven M. Paul, William Z. Potter.